Debiotech has introduced, for the first time worldwide, its SOI-MEMS-based JewelPUMP platform for Diabetes Therapy at the prestigious EASD 2012 conference in Berlin, Germany
Posted date : Dec 12, 2012

Following its much heralded debut at the ADA last year, Debiotech has introduced, for the first time worldwide, its SOI-MEMS-based JewelPUMP platform for Diabetes Therapy at the prestigious EASD 2012 conference in Berlin, Germany. The MEMS device was co-designed and is manufactured by STMicroelectronics. Debiotech, which also presented the results of a successful 2-year intensive study on 35 patients, is now in the stages of final development.